AmSurg’s affordable growth
Posted on November 5, 2009 at 12:47 pmSmartMoney’s Jack Hough has culled through the numbers to unearth some stocks that provide solid growth at a nice price. Among his finds is Nashville-based AmSurg, which from 2005 to 2008 grew its top line by 64 percent and its operating earnings by 57 percent. Today, its shares (Ticker: AMSG) are up about 2 percent, in line with the broader market.
permalink | Comment on this post
AmSurg exec elected to Canadian company’s board
Posted on September 25, 2009 at 12:14 amGene Overholt, a gatroenterology pioneer who has been medical director of AmSurg since 1992 and was a board member of the Nashville company until this past spring, has been elected to the board of CRH Medical, a Vancouver-based company (Toronto Ticker: CRM) that develops hemorrhoid treatments.
permalink | Comment on this post
AmSurg director sells block of stock
Posted on September 9, 2009 at 9:27 amHenry Herr on Friday unloaded more than $300,000 worth of shares in the surgery center operator (Ticker: AMSG) as part of an arranged trading plan.
permalink | Comment on this post
HCA restates cash flow numbers
Posted on August 17, 2009 at 9:41 amThe hospital giant has amended its financial statements to comply with FAS 160, an accounting rule that became effective Jan. 1 and calls for a change in the way companies represent outsiders’ stakes in controlled subsidiaries. The restatement doesn’t affect net income or shareholders’ equity numbers, but does boost the company’s 2006-2008 cash flows from operations by $504 million.
HCA’s move follows that of AmSurg last week. Hmm, think there will be others?
permalink | Comment on this post
AmSurg’s balance-sheet shuffle
Posted on August 11, 2009 at 6:43 amThe surgery center operator said it incorrectly applied a new accounting rule governing minority stakes in joint ventures. The rule, which went into effect at the start of this year, requires AmSurg (Ticker: AMSG) break out the equity held by other parties in its joint ventures and affects about $3 million. See the amended numbers here.
permalink | Comment on this post
Now it’s downgraded
Posted on July 7, 2009 at 10:10 amAmbulatory surgery center operator AmSurg, which yesterday received an upgrade to ‘Buy’ from TheStreet.com Ratings, this morning was downgraded to ‘Neutral’ by Whit Mayo from Robert W. Baird
A Robert W. Baird analyst downgraded outpatient surgery center operator AmSurg Corp. Tuesday, citing a lack of upcoming catalysts and the likelihood the stock will remain flat.
Baird analyst Whit Mayo lowered his rating to “Neutral” from “Outperform” but lowered his price target to $23 from $24, saying the share value has returned to a more reasonable level.
“Thus, outside of a re-acceleration in earnings, we see few significant catalysts and expect the stock to trade sideways,” he wrote in a note to investors.
permalink | Comment on this post
AmSurg rated a ‘Buy’
Posted on July 6, 2009 at 11:39 amTheStreet.com Ratings announced early this morning that it has upgraded surgery center operator AmSurg to “Buy”
The numbers: Fiscal first-quarter revenue rose 12% to $163 million as net income climbed 7.8% to $13 million and earnings per share ascended 8.1% to 40 cents, extending a growth streak to nine quarters. The cash balance is ample with $31 million of reserves. The debt-to-equity ratio is low at 0.6. The net margin is wide at 7.7% but has shed 30 basis points since last year’s first quarter.
The stock: Amsurg is down 10% in 2009, trading at a price-to-earnings ratio of about 13. The company has a market capitalization of $670 million.
BofA launches coverage of health care names
Posted on June 17, 2009 at 9:39 amAnalysts at Bank of America have begun tracking a number of Middle Tennessee health care companies with mostly favorable ratings. Getting ‘buy’ recommendations are Community Health and Psych Solutions. Rated ‘neutral’ for now are Brookdale and LifePoint. The only local ‘underperform’ in BofA’s crop is AmSurg. With the exception of Brookdale, the companies’ stocks are flat or higher this morning.
permalink | Comment on this post
AmSurg Live!
Posted on April 3, 2009 at 11:21 amAmSurg Corp. will provide an online Web simulcast and rebroadcast of its 2009 first-quarter earnings release conference call.
permalink | Comment on this post
Zacks bumps AmSurg to ‘buy’
Posted on March 16, 2009 at 3:20 pmSenior analyst Chris Kallos says the surgery center company has been oversold amid the nervousness over Medicare payments and other health care reform talk. His new price target is $20, more than 20 percent above where the shares (Ticker: AMSG) closed this afternoon.
permalink | Comment on this post
Stifel upgrades AmSurg
Posted on March 11, 2009 at 9:12 amAnalyst Robert Hawkins has lifted his rating on the surgery center operator from ‘hold’ to ‘buy.’ Even after morning’s six-percent jump, his $22 price target for the shares (Ticker: AMSG) leaves about 40 percent of upside.
permalink | Comment on this post
AmSurg inks coding, EHR software deal
Posted on March 10, 2009 at 10:55 amThe Nashville-based surgery center operator (Ticker: AMSG) has signed an agreement with a division of publishing and technology giant Wolters Kluwer to use its software for surgery coding and electronic health records.
permalink | Comment on this post
More blood in health care stocks
Posted on March 2, 2009 at 12:40 pm
The Obama administration’s health care initiatives and the slow economy continue to spook investors in hospitals, surgery centers and just about every other niche that matters to Nashville. Today’s action has taken AmSurg, HealthSpring and Psych Solutions to new 52-week lows.
permalink | Comment on this post
Browsing AmSurg’s 10-K
Posted on February 26, 2009 at 9:56 pmA few quick notes from the annual report filed Thursday by surgery center operator AmSurg:
- The company has acquired three surgery centers (but announced none of them) for a total of $16.5 million. Company execs, who snapped up 40 centers in ‘07 and ‘08, have said in recent months that they see opportunities in a market with far fewer potential buyers.
- The company’s buyback program has spent $12.4 million of the $25 million allotted to it in September and offset the impact of all 2008 stock option exercises. The average price of the shares bought back (Ticker: AMSG) was $24, 60 percent above Thursday’s close.
permalink | Comment on this post
Analyst action: Pinnacle, AmSurg, regional banks
Posted on February 23, 2009 at 7:41 am
Two local stocks that have outperformed the S&P over the past year will start the week backed by upgrades. Wunderlich Securities’ Kevin Reynolds has raised his rating of Pinnacle Financial Partners (Ticker: PNFP) from ‘hold’ to ‘buy.’ Reynolds, who began covering Pinnacle early this month, has kept his price target at $26.
In the same vein, AmSurg shares (Ticker: AMSG) have been raised to ‘outperform’ at both RBC Capital and Robert W. Baird. Bairdm which last month began covering the shares with a ‘neutral’ rating, has however lowered its price target from $27 to $24.
Also getting an upgrade this morning are shares of Synovus Financial, the parent of The Bank of Nashville. Citigroup has raised its rating from ‘hold’ to ‘buy,’ although it did lower its price target on the stock (Ticker: SNV) to $5. Citigroup wasn’t so kind to other regional bank stocks, though, lowering a group that includes Regions Financial (Ticker: RF) from ‘buy’ to ‘hold.’
Go to the Journal’s site for more ratings changes.
Recent Comments
In our good state a select few run the place, 20 yrs ago and today....
Southernindie…Unfortunat ely you have suffered a dibilitating...
And…Karl (Marx) Dean is spending one billion dollars...
Someone explain the difference between short stay and observation...
Watching the Chairman of Starwood Hotels yesterday on CNBC...
Funny how the Union’s feel about taxes. They complained about their...
Where is it?
An absolutely ugly structure, which I have always thought did not take...
Too bad that ATT changed the look of the building so that it no longer...
Yeah, well, look at the TN Legislature of good ol’ boys and the...
As long as the red rules, we will be far behind other states. The GOP does...
Nissan CEO Carlos Ghosn: I don’t know what...